CC
Charles Cherington
10% Owner

Charles Cherington insider trades: Ernexa Therapeutics (ERNA) stock buys and sales

10% Owner, Ernexa Therapeutics Last trade Feb 10, 2026 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$2.0M
Bought, last 12 months
1 buy
13
Open-market trades
since 2021
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Charles reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 10, 2026ERNA↑ Buy$2.0M
Jun 9, 2025ERNA↑ Buy$2.2M
Apr 2, 2025ERNA↑ Buy$394K
Sep 11, 2023CMRA↑ Buy$1.0M
Jul 31, 2023CMRA↑ Buy$450K
Jan 4, 2023CMRA↑ Buy$914K
Dec 2, 2022ERNA↑ Buy$859K
Oct 21, 2022CMRA↑ Buy$24K
Oct 17, 2022CMRA↑ Buy$32K
Oct 13, 2022CMRA↑ Buy$17K
Sep 29, 2022CMRA↑ Buy$33K
Sep 27, 2022CMRA↑ Buy$20K
Jun 17, 2021BTX↓ Sell$6.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Charles Cherington's insider trades

Charles Cherington is a 10% owner of Ernexa Therapeutics (ERNA). Since Jun 17, 2021, Charles has reported 12 open-market purchases worth $8.0M and 1 sale worth $6.3M on SEC Form 4. In the last 12 months: 1 buy ($2.0M).

Their filings also include other transactions (10 filings), grants and awards (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ERNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.